Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor

Cell Reports

Volumn 3, Issue 2, 2013, Pages 342-349

  Mohammed, Hisham ^a   D'Santos, Clive ^a   Serandour, Aurelien A ^a   Ali, H Raza ^a,b   Brown, Gordon D ^a   Atkins, Alan ^c   Rueda, Oscar M ^a   Holmes, Kelly A ^a   Theodorou, Vasiliki ^a   Robinson, Jessica L L ^a   Zwart, Wilbert ^a,d   Saadi, Amel ^a   Ross Innes, Caryn S ^a   Chin, Suet Feung ^a   Menon, Suraj ^a   Stingl, John ^a,e   Palmieri, Carlo ^f   Caldas, Carlos ^a,b,e,g   Carroll, Jason S ^a,e  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c Thermo Fisher Scientific   (United States)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^g Cambridge Experimental Cancer Medicine Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; ESTROGEN RECEPTOR; NUCLEAR RECEPTOR COACTIVATOR; PROTEIN GREB1; REGULATOR PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; CELL INTERACTION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; RAPID IMMUNOPRECIPITATION MASS SPECTROMETRY OF ENDOGENOUS PROTEINS; RECEPTOR BINDING; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICE; MICE, SCID; NEOPLASM PROTEINS; PROTEIN INTERACTION MAPS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 84874243484     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.01.010     Document Type: Article

References (31)

1. Ali S., Coombes R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2002, 2:101-112.
2. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968.
3. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
4. Dunbier A.K., Anderson H., Ghazoui Z., Folkerd E.J., A'hern R., Crowder R.J., Hoog J., Smith I.E., Osin P., Nerurkar A., et al. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. J. Clin. Oncol. 2010, 28:1161-1167.
5. Ghosh M.G., Thompson D.A., Weigel R.J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 2000, 60:6367-6375.
6. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997, 387:733-736.
7. Hnatyszyn H.J., Liu M., Hilger A., Herbert L., Gomez-Fernandez C.R., Jorda M., Thomas D., Rae J.M., El-Ashry D., Lippman M.E. Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody. Breast Cancer Res. Treat. 2010, 122:371-380.
8. Holmes K.A., Hurtado A., Brown G.D., Launchbury R., Ross-Innes C.S., Hadfield J., Odom D.T., Carroll J.S. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proc. Natl. Acad. Sci. USA 2012, 109:2748-2753.
9. Hua S., Kittler R., White K.P. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 2009, 137:1259-1271.
10. Liu M., Wang G., Gomez-Fernandez C.R., Guo S. GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer. PLoS ONE 2012, 7:e46410.
11. Magnani L., Ballantyne E.B., Zhang X., Lupien M. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PLoS Genet. 2011, 7:e1002368.
12. Malovannaya A., Li Y., Bulynko Y., Jung S.Y., Wang Y., Lanz R.B., O'Malley B.W., Qin J. Streamlined analysis schema for high-throughput identification of endogenous protein complexes. Proc. Natl. Acad. Sci. USA 2010, 107:2431-2436.
13. Malovannaya A., Lanz R.B., Jung S.Y., Bulynko Y., Le N.T., Chan D.W., Ding C., Shi Y., Yucer N., Krenciute G., et al. Analysis of the human endogenous coregulator complexome. Cell 2011, 145:787-799.
14. McCune K., Bhat-Nakshatri P., Thorat M.A., Nephew K.P., Badve S., Nakshatri H. Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet. Cancer Res. 2010, 70:685-696.
15. Métivier R., Penot G., Hübner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
16. Okada M., Takezawa S., Mezaki Y., Yamaoka I., Takada I., Kitagawa H., Kato S. Switching of chromatin-remodelling complexes for oestrogen receptor-alpha. EMBO Rep. 2008, 9:563-568.
17. Oyama M., Nagashima T., Suzuki T., Kozuka-Hata H., Yumoto N., Shiraishi Y., Ikeda K., Kuroki Y., Gotoh N., Ishida T., et al. Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer. J. Biol. Chem. 2011, 286:818-829.
18. Rae J.M., Johnson M.D., Scheys J.O., Cordero K.E., Larios J.M., Lippman M.E. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res. Treat. 2005, 92:141-149.
19. Rae J.M., Johnson M.D., Cordero K.E., Scheys J.O., Larios J.M., Gottardis M.M., Pienta K.J., Lippman M.E. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 2006, 66:886-894.
20. Robinson J.L., Macarthur S., Ross-Innes C.S., Tilley W.D., Neal D.E., Mills I.G., Carroll J.S. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J. 2011, 30:3019-3027.
21. Ross-Innes C.S., Stark R., Holmes K.A., Schmidt D., Spyrou C., Russell R., Massie C.E., Vowler S.L., Eldridge M., Carroll J.S. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev. 2010, 24:171-182.
22. Ross-Innes C.S., Stark R., Teschendorff A.E., Holmes K.A., Ali H.R., Dunning M.J., Brown G.D., Gojis O., Ellis I.O., Green A.R., et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 2012, 481:389-393.
23. Selbach M., Mann M. Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK). Nat. Methods 2006, 3:981-983.
24. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103:843-852.
25. Shen C., Huang Y., Liu Y., Wang G., Zhao Y., Wang Z., Teng M., Wang Y., Flockhart D.A., Skaar T.C., et al. A modulated empirical Bayes model for identifying topological and temporal estrogen receptor α regulatory networks in breast cancer. BMC Syst. Biol. 2011, 5:67.
26. Stossi F., Likhite V.S., Katzenellenbogen J.A., Katzenellenbogen B.S. Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J. Biol. Chem. 2006, 281:16272-16278.
27. Sutherland B.W., Toews J., Kast J. Utility of formaldehyde cross-linking and mass spectrometry in the study of protein-protein interactions. J. Mass Spectrom. 2008, 43:699-715.
28. Tan S.K., Lin Z.H., Chang C.W., Varang V., Chng K.R., Pan Y.F., Yong E.L., Sung W.K., Cheung E. AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J. 2011, 30:2569-2581.
29. Theodorou V., Stark R., Menon S., Carroll J.S. GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res. 2013, 23:12-22.
30. Torres-Arzayus M.I., Font de Mora J., Yuan J., Vazquez F., Bronson R., Rue M., Sellers W.R., Brown M. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004, 6:263-274.
31. Zwart W., Theodorou V., Kok M., Canisius S., Linn S., Carroll J.S. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. EMBO J. 2011, 30:4764-4776.